Lupin's partner Natco obtains FDA nod for generic TracleerNatco is the first-to-file for this product and is eligible for 180 days exclusivity. Axsome, Teva settle litigation over AuvelityAxsome will grant Teva a license to sell its generic version of Auvelity beginning on or after March 31, 2039, if pediatric exclusivity is granted, or on or after Sept. 30, 2038, if no pediatric exclusivity is granted. Alembic releases generic Dilacor Diltiazem HcL ER capsules are indicated for the treatment of hypertension. Generic drug suppliers weigh in on predictable, unpredictable category impact Generic drug suppliers weigh predictable and unpredictable factors that could impact the category in 2025. Fresenius Kabi intros calcitonin salmon injection Calcitonin salmon injection is used to treat Paget’s disease, hypercalcemia and postmenopausal osteoporosis. Dr. Reddy’s, Henlius to co-market Darzalex & Darzalex Faspro biosimilar in the U.S., Europe Darzalex & Darzalex Faspro are indicated for the treatment of multiple myeloma. AAM releases 2025 advocacy priorities, legislative reform recommendations The recommendations are a call to action to safeguard affordable generic and biosimilar medicines. FDA gives Lupin tentative nod for generic Symtuza Generic Symtuza is used to treat HIV. Biosimilar Council comments on IQVIA report on biosimilar void AAM said the report highlights that 90% of the brand biologics scheduled to lose exclusivity in the next 10 years do not have biosimilars in development. Cosette taps Brad Leonard for VP, generics commercial operations Leonard will spearhead Cosette’s generics business, including generics sales, marketing/pricing, customer service and demand planning. 1 2 3 4 5 Next Last
